ZUG, Switzerland, and BOSTON, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company purposefully driven to save sight and improve eye care, ...
Announcing a new article publication in BIO Integration. Ocular drug delivery systems are essential for treating various eye conditions. Ocular conventional drug delivery techniques, such as eye drops ...
Phase 3 DIAMOND-1 and DIAMOND-2 trials enrollment of OCS-01 in diabetic macular edema (DME) accelerated with great momentum DIAMOND program committees expanded with globally renowned retina experts If ...
Please provide your email address to receive an email when new articles are posted on . VIENNA — During the “presbyopia game changers” symposium at the ESCRS meeting, Elizabeth Yeu, MD, gave an update ...
Children who took short-term topical atropine eye drops, 0.01% to 1.0%, had no difference in final refractive errors 10 to 20 years after treatment. Taking short-term topical atropine eye drops, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results